Literature DB >> 18227708

Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient.

Mepur H Ravindranath1, Sakunthala Muthugounder, Naftali Presser.   

Abstract

The primary cutaneous melanoma initially migrates to the regional lymph nodes (LNs). Human melanoma overexpresses gangliosides, the sialylglycosphingolipids. The ganglioside signatures may differ between primary and LN melanomas owing to the differences in the tumor microenvironments. The melanoma cells obtained from the primary and LN of the same patient might be useful to evaluate the above hypothesis. For this purpose, the cryopreserved cell lines from a primary cutaneous melanoma (IGR-39) and its nodal metastasis (IGR-37) from the same patient were used. We have also compared the ganglioside signatures of freshly obtained melanoma cells from primary, LN and organ metastases from different patients. Gangliosides were extracted, purified and identified by resorcinol and specific murine monoclonal antibodies. Comparison of the primary cell line with the nodal metastatic line obtained from the same patient distinctly showed the following features: (i) an increased production of gangliosides, (ii) O-acetylation of GM2 and GD3, (iii) an increased and altered O-acetylation of GD2 and (iv) possibly de-N-acetylation of GD3. These findings suggest that the nodal microenvironment might favor activation of O-acetyl-transferases capable of O-acetylating both alpha2, 3 and alpha2, 8 sialic acids of gangliosides. Supporting this, the primary melanoma cells obtained from different patients, showed no O-acetylation of GD3 or GD2. The cell line from groin LN showed the presence of O-acetyl (O-Ac)GD3. The cell lines from thyroid, spleen and jejunum expressed O-AcGD2. In all metastatic melanoma cell lines GD1a is more prevalent than GD3, suggesting that GD1a may be a major melanoma-ganglioside.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227708     DOI: 10.1097/CMR.0b013e3282f43acf

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  9 in total

1.  Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells.

Authors:  Eric Yvon; Michele Del Vecchio; Barbara Savoldo; Valentina Hoyos; Aurélie Dutour; Andrea Anichini; Gianpietro Dotti; Malcolm K Brenner
Journal:  Clin Cancer Res       Date:  2009-09-08       Impact factor: 12.531

2.  A method for visualization of "omic" datasets for sphingolipid metabolism to predict potentially interesting differences.

Authors:  Amin A Momin; Hyejung Park; Brent J Portz; Christopher A Haynes; Rebecca L Shaner; Samuel L Kelly; I King Jordan; Alfred H Merrill
Journal:  J Lipid Res       Date:  2011-03-17       Impact factor: 5.922

3.  Anti-GD2/4-1BB chimeric antigen receptor T cell therapy for the treatment of Chinese melanoma patients.

Authors:  Jiayi Yu; Xiaowen Wu; Junya Yan; Huan Yu; Longwen Xu; Zhihong Chi; Xinan Sheng; Lu Si; Chuanliang Cui; Jie Dai; Meng Ma; Tianxiao Xu; Yan Kong; Jun Guo
Journal:  J Hematol Oncol       Date:  2018-01-03       Impact factor: 17.388

Review 4.  Functions and Biosynthesis of O-Acetylated Sialic Acids.

Authors:  Chitra Mandal; Reinhard Schwartz-Albiez; Reinhard Vlasak
Journal:  Top Curr Chem       Date:  2015

5.  O-Acetylated sialic acids and their role in immune defense.

Authors:  Roland Schauer; G Vinayaga Srinivasan; Dirk Wipfler; Bernhard Kniep; Reinhard Schwartz-Albiez
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

Review 6.  Is immunotherapy in the future of therapeutic management of sarcomas?

Authors:  Ottavia Clemente; Alessandro Ottaiano; Giuseppe Di Lorenzo; Alessandra Bracigliano; Sabrina Lamia; Lucia Cannella; Antonio Pizzolorusso; Massimiliano Di Marzo; Mariachiara Santorsola; Annarosaria De Chiara; Flavio Fazioli; Salvatore Tafuto
Journal:  J Transl Med       Date:  2021-04-26       Impact factor: 5.531

7.  Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrix-assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF-MS).

Authors:  Stephanie Holst; Kathrin Stavenhagen; Crina I A Balog; Carolien A M Koeleman; Liam M McDonnell; Oleg A Mayboroda; Aswin Verhoeven; Wilma E Mesker; Rob A E M Tollenaar; André M Deelder; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2013-07-22       Impact factor: 5.911

8.  Antiganglioside Antibodies and Inflammatory Response in Cutaneous Melanoma.

Authors:  Corina Daniela Ene; Mircea Tampa; Ilinca Nicolae; Cristina Iulia Mitran; Madalina Irina Mitran; Clara Matei; Ana Caruntu; Constantin Caruntu; Simona Roxana Georgescu
Journal:  J Immunol Res       Date:  2020-08-13       Impact factor: 4.818

9.  Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells.

Authors:  Sophia B Strobel; Devayani Machiraju; Ingrid Hülsmeyer; Jürgen C Becker; Annette Paschen; Dirk Jäger; Winfried S Wels; Michael Bachmann; Jessica C Hassel
Journal:  Life (Basel)       Date:  2021-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.